Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Greenland Mines | Mr. Jeffrey Brian LeBlanc | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.18 per share. | 16 Jul 2026 | 1,400,000 | 4,820,342 | - | 0.2 | 245,280 | Common Stock |
| Immuneering Corp (Class A) | Mr. Andrew Gengos, M.B.A. | Chief Financial Officer | 16 Jul 2026 | 650,000 | 650,000 | - | - | Stock Option | ||
| Korsana Biosciences Inc | Peter M. Hecht | Director, Ten Percent Owner | 16 Jul 2026 | 351,037 | 910,240 (3%) | 1% | - | Common Stock | ||
| Korsana Biosciences Inc | Peter M. Hecht | Director, Ten Percent Owner | 16 Jul 2026 | 351,037 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Pagerduty Inc | Ms. Jennifer G. Tejada | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 10.70 per share. | 16 Jul 2026 | 302,100 | 1,678,251 (2%) | 0% | 10.7 | 3,232,470 | Common Stock |
| Pagerduty Inc | Ms. Jennifer G. Tejada | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 16 Jul 2026 | 302,100 | 1,980,351 (2%) | 0% | 2 | 604,200 | Common Stock |
| Pagerduty Inc | Ms. Jennifer G. Tejada | Director, Executive Chair | 16 Jul 2026 | 302,100 | 96,847 | - | - | Stock Option (Right to Buy) | ||
| Microvision Inc | Mr. Robert P. Carlile | Director | 16 Jul 2026 | 280,152 | 280,152 | - | - | Restricted Stock Units | ||
| Microvision Inc | Ms. Laura J. Peterson | Director | 16 Jul 2026 | 280,152 | 280,152 | - | - | Restricted Stock Units | ||
| Microvision Inc | Mr. Jeffrey A. Herbst | Director | 16 Jul 2026 | 280,152 | 280,152 | - | - | Restricted Stock Units | ||
| Microvision Inc | Mr. Peter Schabert | Director | 16 Jul 2026 | 280,152 | 280,152 | - | - | Restricted Stock Units | ||
| Microvision Inc | Ms. Jada M. Smith | Director | 16 Jul 2026 | 280,152 | 280,152 | - | - | Restricted Stock Units | ||
| Select Energy Services Inc (Class A) | Mr. John D. Schmitz | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 250,000 | 536,436 (0%) | 0% | 0 | Class A Common Stock | |
| Cingulate Inc | Dr. Shane J. Schaffer, Pharm.D. | Director, Chief Executive Officer | 16 Jul 2026 | 197,650 | 197,650 | - | - | Stock Option (right to Buy) | ||
| Elicio Therapeutics Inc | Mr. Robert Connelly | Director, CEO, President and Director | 16 Jul 2026 | 186,944 | 186,944 | - | - | Stock Option (Right to Buy) | ||
| Adma Biologics Inc | Mr. P. Terence Kohler, Jr | CFO and Treasurer | 16 Jul 2026 | 136,363 | 136,363 | - | - | Stock Option (Right to Buy) | ||
| Q32 Bio Inc | Ms. Jodie P. Morrison | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 132,000 | 353,104 | - | 0 | Common Stock | |
| Select Energy Services Inc (Class A) | Mr. John D. Schmitz | Director, President & CEO | 16 Jul 2026 | 125,000 | 125,000 | - | - | Performance Share Units | ||
| Select Energy Services Inc (Class A) | Mr. John D. Schmitz | Director, President & CEO | 16 Jul 2026 | 125,000 | 125,000 | - | - | Performance Share Units | ||
| Select Energy Services Inc (Class A) | Mr. John D. Schmitz | Director, President & CEO | 16 Jul 2026 | 125,000 | 125,000 | - | - | Performance Share Units | ||
| Select Energy Services Inc (Class A) | Mr. John D. Schmitz | Director, President & CEO | 16 Jul 2026 | 125,000 | 125,000 | - | - | Performance Share Units | ||
| Select Energy Services Inc (Class A) | Mr. John D. Schmitz | Director, President & CEO | 16 Jul 2026 | 125,000 | 125,000 | - | - | Performance Share Units | ||
| Select Energy Services Inc (Class A) | Mr. John D. Schmitz | Director, President & CEO | 16 Jul 2026 | 125,000 | 125,000 | - | - | Performance Share Units | ||
| Select Energy Services Inc (Class A) | Mr. John D. Schmitz | Director, President & CEO | 16 Jul 2026 | 125,000 | 125,000 | - | - | Performance Share Units | ||
| Select Energy Services Inc (Class A) | Mr. John D. Schmitz | Director, President & CEO | 16 Jul 2026 | 125,000 | 125,000 | - | - | Performance Share Units | ||
| Select Energy Services Inc (Class A) | Mr. John D. Schmitz | Director, President & CEO | 16 Jul 2026 | 125,000 | 125,000 | - | - | Performance Share Units | ||
| PLAYSTUDIOS Inc (Class A) | Mr. Jason Krikorian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 120,000 | 364,992 | - | 0 | Class A Common Stock | |
| PLAYSTUDIOS Inc (Class A) | Mr. Hyman Joseph Horowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 120,000 | 364,992 | - | 0 | Class A Common Stock | |
| PLAYSTUDIOS Inc (Class A) | Mr. Steve J. Zanella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 120,000 | 364,992 | - | 0 | Class A Common Stock | |
| Caredx Inc | Mr. John Walter Hanna, Jr | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.20 per share. | 16 Jul 2026 | 118,000 | 771,448 (1%) | 0% | 8.2 | 967,600 | Common Stock |
| Caredx Inc | Mr. John Walter Hanna, Jr | Director, President and CEO | 16 Jul 2026 | 118,000 | 512,706 | - | - | Employee Stock Option (Right to Buy) | ||
| Cingulate Inc | Dr. Shane J. Schaffer, Pharm.D. | Director, Chief Executive Officer | 16 Jul 2026 | 97,350 | 97,350 | - | - | Stock Option (right to Buy) | ||
| Pagerduty Inc | Ms. Jennifer G. Tejada | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 16 Jul 2026 | 96,847 | 1,678,251 (2%) | 0% | 10.4 | 1,008,468 | Common Stock |
| Pagerduty Inc | Ms. Jennifer G. Tejada | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 16 Jul 2026 | 96,847 | 1,775,098 (2%) | 0% | 2 | 193,694 | Common Stock |
| Pagerduty Inc | Ms. Jennifer G. Tejada | Director, Executive Chair | 16 Jul 2026 | 96,847 | 0 | - | - | Stock Option (Right to Buy) | ||
| Flywire Corp | Mr. Michael Massaro | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.62 per share. | 16 Jul 2026 | 92,672 | 2,585,379 | - | 18.6 | 1,725,729 | Voting Common Stock |
| Adma Biologics Inc | Mr. P. Terence Kohler, Jr | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 85,130 | 143,149 (0%) | 0% | 0 | Common Stock | |
| MediaAlpha Inc (Class A) | Mr. Steven M. Yi | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 14.39 per share. | 16 Jul 2026 | 82,457 | 2,472,023 | - | 14.4 | 1,186,564 | Class A Common Stock |
| Health Catalyst Inc | Mr. Justin R. Spencer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 80,691 | 149,263 (0%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | Mr. Steven H. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 80,691 | 235,499 (0%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | Ms. Julie Larson-Green | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 80,691 | 175,335 (0%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | Dr. Jill Hoggard Green, M.S. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 80,691 | 144,628 (0%) | 0% | 0 | Common Stock | |
| Incyte | Mr. William J. Meury | Director, Chief Executive Officer | 16 Jul 2026 | 80,421 | 80,421 | - | - | Performance Shares | ||
| Intensity Therapeutics Inc | Mr. Lewis H. Bender | Director, President and CEO | 16 Jul 2026 | 78,000 | 78,000 | - | - | Stock Option (right to buy Common Stock) | ||
| Incyte | Mr. William J. Meury | Director, Chief Executive Officer | 16 Jul 2026 | 77,148 | 77,148 | - | - | Employee Stock Option (right to buy) | ||
| Caredx Inc | Mr. John Walter Hanna, Jr | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 39.01 per share. | 16 Jul 2026 | 68,000 | 653,448 (1%) | 0% | 39.0 | 2,652,932 | Common Stock |
| Evolv Tech Holdings Inc (Class A) | Mr. Kevin M. Charlton | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Jul 2026 | 67,500 | 291,510 | - | 0 | - | |
| Cingulate Inc | Mr. Bryan Wade Downey | EVP & Chief Commercial Officer | 16 Jul 2026 | 67,000 | 67,000 | - | - | Stock Option (right to Buy) | ||
| Elicio Therapeutics Inc | Dr. Christopher Haqq, M.D.,PhD | See Remarks | 16 Jul 2026 | 64,643 | 64,643 | - | - | Stock Option (Right to Buy) | ||
| Elicio Therapeutics Inc | Dr. Preetam Shah, M.B.A.,PhD | See Remarks | 16 Jul 2026 | 60,833 | 60,833 | - | - | Stock Option (Right to Buy) | ||
| Payoneer Global Inc | Ms. Beatrice Ordonez | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.09 per share. | 16 Jul 2026 | 60,485 | 2,826,781 | - | 7.1 | 428,839 | Common Stock |
| W & T Offshore Inc | Mr. Daniel O. Conwill,IV | Director | Sale of securities on an exchange or to another person at price $ 3.41 per share. | 16 Jul 2026 | 60,000 | 191,076 (0%) | 0% | 3.4 | 204,600 | Common Stock |
| Incyte | Dr. Pablo J. Cagnoni, M.D. | President, Global Head of R&D | 16 Jul 2026 | 57,861 | 57,861 | - | - | Employee Stock Option (right to buy) | ||
| Cingulate Inc | Dr. Raul R. Silva, M.D. | EVP and CSO | 16 Jul 2026 | 53,600 | 53,600 | - | - | Stock Option (right to Buy) | ||
| Cingulate Inc | Dr. Matthew N. Brams, M.D. | EVP and Chief Medical Officer | 16 Jul 2026 | 53,600 | 53,600 | - | - | Stock Option (right to Buy) | ||
| Elicio Therapeutics Inc | Dr. Peter DeMuth, PhD | Chief Scientific Officer | 16 Jul 2026 | 52,832 | 52,832 | - | - | Stock Option (Right to Buy) | ||
| Caredx Inc | Mr. John Walter Hanna, Jr | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 36.11 per share. | 16 Jul 2026 | 50,000 | 721,448 (1%) | 0% | 36.1 | 1,805,705 | Common Stock |
| Prologis | Mr. Hamid R. Moghadam | Director | Sale of securities on an exchange or to another person at price $ 149.91 per share. | 16 Jul 2026 | 50,000 | 969,089 (0%) | 0% | 149.9 | 7,495,500 | Common Stock |
| Stitch Fix Inc (Class A) | Mr. Casey OConnor | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 3.93 per share. | 16 Jul 2026 | 50,000 | 429,618 (0%) | 0% | 3.9 | 196,560 | Class A Common Stock |
| Incyte | Dr. Steven H. Stein, M.D. | CMO & Head of Late-Stage Dev. | 16 Jul 2026 | 42,298 | 42,298 | - | - | Employee Stock Option (right to buy) | ||
| Cingulate Inc | Ms. Jennifer L. Callahan | EVP and CFO | 16 Jul 2026 | 40,200 | 40,200 | - | - | Stock Option (right to Buy) | ||
| Q32 Bio Inc | Dr. Shelia M. Violette, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 37,500 | 130,569 | - | 0 | Common Stock | |
| Nerdy Inc (Class A) | Mr. Atul M. Bagga | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.83 per share. | 16 Jul 2026 | 36,426 | 1,463,574 | - | 0.8 | 30,234 | Class A Common Stock |
| Intensity Therapeutics Inc | Mr. Joseph Talamo | Chief Financial Officer | 16 Jul 2026 | 34,000 | 34,000 | - | - | Stock Option (right to buy Common Stock) | ||
| Incyte | Mr. Mohamed Khairie Issa | EVP, Head of U.S. Commercial | 16 Jul 2026 | 33,918 | 33,918 | - | - | Employee Stock Option (right to buy) | ||
| Incyte | Dr. Pablo J. Cagnoni, M.D. | President, Global Head of R&D | 16 Jul 2026 | 33,508 | 33,508 | - | - | Performance Shares | ||
| Performance Food Grp Co | Mr. George L. Holm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.57 per share. | 16 Jul 2026 | 33,000 | 1,654,552 (1%) | 0% | 26.6 | 876,810 | Common Stock |
| Performance Food Grp Co | Mr. George L. Holm | Director, See Remarks | 16 Jul 2026 | 33,000 | 29,131 | - | - | Options (Right to Buy) | ||
| Cingulate Inc | Mr. Bryan Wade Downey | EVP & Chief Commercial Officer | 16 Jul 2026 | 33,000 | 33,000 | - | - | Stock Option (right to Buy) | ||
| Flywire Corp | Mr. Michael Massaro | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.20 per share. | 16 Jul 2026 | 32,328 | 2,553,051 | - | 18.2 | 588,295 | Voting Common Stock |
| Incyte | Mr. David H. Gardner | EVP, Chief Strategy Officer | 16 Jul 2026 | 31,923 | 31,923 | - | - | Employee Stock Option (right to buy) | ||
| Incyte | Mr. Richard A. Hoffman | EVP & General Counsel | 16 Jul 2026 | 31,923 | 31,923 | - | - | Employee Stock Option (right to buy) | ||
| Performance Food Grp Co | Mr. George L. Holm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 112.83 per share. | 16 Jul 2026 | 31,297 | 1,621,852 (1%) | 0% | 112.8 | 3,531,241 | Common Stock |
| Skillsoft Corp (Class A) | Mr. Ronald W. Hovsepian | Director, CEO & Executive Chair | 16 Jul 2026 | 31,250 | 218,750 | - | - | Restricted Stock Units | ||
| Skillsoft Corp (Class A) | Mr. Ronald W. Hovsepian | Director, CEO & Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 31,250 | 341,349 | - | 0 | Class A Common Stock | |
| Nerdy Inc (Class A) | Mr. John A. Paszterko | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.83 per share. | 16 Jul 2026 | 31,034 | 1,718,721 | - | 0.8 | 25,758 | Class A Common Stock |
| Nextdoor Holdings Inc (Class A) | Mr. Craig Lisowski | President of Products | Sale of securities on an exchange or to another person at price $ 2.51 per share. | 16 Jul 2026 | 30,000 | 1,724,123 | - | 2.5 | 75,195 | Class A Common Stock |
| Stoke Therapeutics Inc | Dr. Seth L. Harrison, M.D. | Director | 16 Jul 2026 | 29,747 | 29,747 | - | - | Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Dr. Seth L. Harrison, M.D. | Director | 16 Jul 2026 | 29,747 | 0 | - | - | Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Dr. Seth L. Harrison, M.D. | Director | 16 Jul 2026 | 29,555 | 0 | - | - | Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Dr. Seth L. Harrison, M.D. | Director | 16 Jul 2026 | 29,555 | 29,555 | - | - | Stock Option (Right to Buy) | ||
| Caredx Inc | Dr. Hannah A. Valantine, M.D. | Director | Sale of securities on an exchange or to another person at price $ 36.14 per share. | 16 Jul 2026 | 28,679 | 36,786 (0%) | 0% | 36.1 | 1,036,588 | Common Stock |
| Life360 Inc | Mr. Chris Hulls | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.53 per share. | 16 Jul 2026 | 27,000 | 433,899 | - | 2.5 | 68,310 | Common Stock |
| Life360 Inc | Mr. Chris Hulls | Director | 16 Jul 2026 | 27,000 | 1,242,386 | - | - | Stock Option (right to buy) | ||
| Incyte | Mr. William J. Meury | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 26,807 | 183,129 (0%) | 0% | 0 | Common Stock | |
| Cingulate Inc | Dr. Raul R. Silva, M.D. | EVP and CSO | 16 Jul 2026 | 26,400 | 26,400 | - | - | Stock Option (right to Buy) | ||
| Cingulate Inc | Dr. Matthew N. Brams, M.D. | EVP and Chief Medical Officer | 16 Jul 2026 | 26,400 | 26,400 | - | - | Stock Option (right to Buy) | ||
| Fuelcell Energy Inc | Mr. Homer John Livingston, III | Director | Purchase of securities on an exchange or from another person at price $ 18.79 per share. | 16 Jul 2026 | 26,343 | 26,343 (0%) | 0% | 18.8 | 494,967 | Common Stock |
| Incyte | Mr. Patrick A. Mayes | EVP & Chief Scientific Officer | 16 Jul 2026 | 25,538 | 25,538 | - | - | Employee Stock Option (right to buy) | ||
| Bank of New York Mellon | Robin A. Vince | Director, Chairman & CEO | Other type of transaction at price $ 161.07 per share. | 16 Jul 2026 | 24,833 | 24,833 (0%) | 0% | 161.1 | 3,999,975 | Common Stock |
| Bank of New York Mellon | Robin A. Vince | Director, Chairman & CEO | Other type of transaction at price $ 161.07 per share. | 16 Jul 2026 | 24,833 | 625,794 (0%) | 0% | 161.1 | 3,999,975 | Common Stock |
| BlackRock New York Municipal Income Trust | Mr. Robin A. Vince | Director, Chairman & CEO | Other type of transaction at price $ 161.07 per share. | 16 Jul 2026 | 24,833 | 625,794 (0%) | 0% | 161.1 | 3,999,975 | - |
| BlackRock New York Municipal Income Trust | Mr. Robin A. Vince | Director, Chairman & CEO | Other type of transaction at price $ 161.07 per share. | 16 Jul 2026 | 24,833 | 24,833 (0%) | 0% | 161.1 | 3,999,975 | - |
| Incyte | Dr. Steven H. Stein, M.D. | CMO & Head of Late-Stage Dev. | 16 Jul 2026 | 24,496 | 24,496 | - | - | Performance Shares | ||
| Torrid Holdings Inc | Ms. Chinwe Abaelu | See Remarks | Sale of securities on an exchange or to another person at price $ 2.16 per share. | 16 Jul 2026 | 24,401 | 202,461 | - | 2.2 | 52,706 | Common Stock |
| Snap Inc (Class A) | Mr. Ajit Mohan | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 4.72 per share. | 16 Jul 2026 | 24,263 | 5,026,705 (0%) | 0% | 4.7 | 114,456 | Class A Common Stock |
| Vaxcyte Inc | Dr. John H. Markels, PhD | Director | 16 Jul 2026 | 23,029 | 23,029 | - | - | Stock Option (right to buy) | ||
| Nerdy Inc (Class A) | Mr. Chris Swenson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 0.83 per share. | 16 Jul 2026 | 22,707 | 2,468,924 | - | 0.8 | 18,847 | Class A Common Stock |
| Incyte | Mr. Ramitpal K. Basi | EVP, Human Resources | 16 Jul 2026 | 21,548 | 21,548 | - | - | Employee Stock Option (right to buy) | ||
| Stoke Therapeutics Inc | Dr. Seth L. Harrison, M.D. | Director | 16 Jul 2026 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Dr. Seth L. Harrison, M.D. | Director | 16 Jul 2026 | 21,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Infrared Cameras Holdings Inc | Mr. Asim Akram | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 20,841 | 25,201 | - | 0 | Common Stock | |
| Aehr Test Systems | Mr. Geoffrey G. Scott | Director | Sale of securities on an exchange or to another person at price $ 82.13 per share. | 16 Jul 2026 | 20,000 | 30,000 (0%) | 0% | 82.1 | 1,642,650 | Common Stock |
| Cingulate Inc | Mr. Jeff Hargroves | Director | 16 Jul 2026 | 20,000 | 20,000 | - | - | Stock Option (right to Buy) | ||
| Cingulate Inc | Mr. Peter J. Werth | Director | 16 Jul 2026 | 20,000 | 20,000 | - | - | Stock Option (right to Buy) | ||
| Cingulate Inc | Mr. Bryan Lawrence | Director | 16 Jul 2026 | 20,000 | 20,000 | - | - | Stock Option (right to Buy) | ||
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | 16 Jul 2026 | 20,000 | 270,059 | - | - | Class B Common Stock | ||
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | 16 Jul 2026 | 20,000 | 21,640 (0%) | 0% | 0 | Class A Common Stock | ||
| Cingulate Inc | Ms. Jennifer L. Callahan | EVP and CFO | 16 Jul 2026 | 19,800 | 19,800 | - | - | Stock Option (right to Buy) | ||
| Incyte | Mr. Mohamed Khairie Issa | EVP, Head of U.S. Commercial | 16 Jul 2026 | 19,643 | 19,643 | - | - | Performance Shares | ||
| Stoke Therapeutics Inc | Dr. Seth L. Harrison, M.D. | Director | 16 Jul 2026 | 19,441 | 19,441 | - | - | Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Dr. Seth L. Harrison, M.D. | Director | 16 Jul 2026 | 19,441 | 0 | - | - | Stock Option (Right to Buy) | ||
| Angiodynamic Inc | Mr. James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.14 per share. | 16 Jul 2026 | 18,588 | 863,941 (2%) | 0% | 14.1 | 262,834 | Common Stock |
| Incyte | Mr. David H. Gardner | EVP, Chief Strategy Officer | 16 Jul 2026 | 18,487 | 18,487 | - | - | Performance Shares | ||
| Incyte | Mr. Richard A. Hoffman | EVP & General Counsel | 16 Jul 2026 | 18,487 | 18,487 | - | - | Performance Shares | ||
| BlackRock | Mr. Christopher J. Meade | General Counsel and CLO | 16 Jul 2026 | 18,095 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| BlackRock | Mr. Christopher J. Meade | General Counsel and CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 513.50 per share. | 16 Jul 2026 | 18,095 | 32,154 (0%) | 0% | 513.5 | 9,291,783 | Common Stock |
| Infrared Cameras Holdings Inc | Mr. Robert Nadolny | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 17,935 | 23,491 | - | 0 | Common Stock | |
| Stoke Therapeutics Inc | Dr. Seth L. Harrison, M.D. | Director | 16 Jul 2026 | 17,786 | 17,786 | - | - | Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Dr. Seth L. Harrison, M.D. | Director | 16 Jul 2026 | 17,786 | 0 | - | - | Stock Option (Right to Buy) | ||
| Evolv Tech Holdings Inc (Class A) | Mr. Neil Glat | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Jul 2026 | 17,500 | 234,600 | - | 0 | - | |
| Cerus Corp | Mr. Vivek K. Jayaraman | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.16 per share. | 16 Jul 2026 | 16,666 | 2,232,211 (1%) | 0% | 3.2 | 52,665 | Common Stock |
| Caredx Inc | Dr. Hannah A. Valantine, M.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.19 per share. | 16 Jul 2026 | 16,048 | 60,340 (0%) | 0% | 14.2 | 227,721 | Common Stock |
| Caredx Inc | Dr. Hannah A. Valantine, M.D. | Director | 16 Jul 2026 | 16,048 | 0 | - | - | Stock Option (Right to Buy) | ||
| Kinder Morgan (Class P) | Mr. Michael P. Garthwaite | VP (Pres., Products Pipelines) | 16 Jul 2026 | 15,915 | 0 | - | - | Restricted Stock Unit | ||
| Kinder Morgan (Class P) | Mr. Michael P. Garthwaite | VP (Pres., Products Pipelines) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 15,915 | 56,108 (0%) | 0% | 0 | Class P Common Stock | |
| BlackRock | Mr. Christopher J. Meade | General Counsel and CLO | Sale of securities on an exchange or to another person at price $ 1101.99 per share. | 16 Jul 2026 | 15,895 | 16,259 (0%) | 0% | 1102.0 | 17,516,188 | Common Stock |
| Intercontinental Exchange | Ms. Lynn C. Martin | President, NYSE Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.31 per share. | 16 Jul 2026 | 15,882 | 70,302 (0%) | 0% | 57.3 | 910,197 | Common Stock |
| Intercontinental Exchange | Ms. Lynn C. Martin | President, NYSE Group | 16 Jul 2026 | 15,882 | 0 | - | - | Employee Stock Option (right to buy) Holding | ||
| Rayonier Advanced Materials Inc | Mr. Christian Antoine Lucien Ribeyrolle | SVP, High Purity Cellulose | 16 Jul 2026 | 15,840 | 15,840 | - | - | Restricted Stock Units | ||
| Core Scientific Inc - Ordinary Shares - New | Mr. Adam Taylor Sullivan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.72 per share. | 16 Jul 2026 | 15,584 | 4,436,426 | - | 22.7 | 354,068 | Common Stock |
| Evolv Tech Holdings Inc (Class A) | Mr. Neil Glat | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Jul 2026 | 15,091 | 219,509 | - | 0 | - | |
| Remitly Global Inc | Mr. Pankaj Sharma | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 16 Jul 2026 | 15,000 | 752,810 | - | 25.0 | 375,450 | Common Stock |
| Jasper Therapeutics Inc | Mr. Patrick J. Crutcher | Director | 16 Jul 2026 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy | ||
| Incyte | Mr. Patrick A. Mayes | EVP & Chief Scientific Officer | 16 Jul 2026 | 14,790 | 14,790 | - | - | Performance Shares | ||
| Stoke Therapeutics Inc | Dr. Seth L. Harrison, M.D. | Director | 16 Jul 2026 | 14,777 | 14,777 | - | - | Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Dr. Seth L. Harrison, M.D. | Director | 16 Jul 2026 | 14,777 | 0 | - | - | Stock Option (Right to Buy) | ||
| InnovAge Holding Corp | Mr. Patrick Blair | CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.87 per share. | 16 Jul 2026 | 14,453 | 672,650 | - | 11.9 | 171,557 | Common Stock, $0.001 par value |
| Life360 Inc | Mr. Chris Hulls | Director | Sale of securities on an exchange or to another person at price $ 55.74 per share. | 16 Jul 2026 | 14,345 | 419,554 | - | 55.7 | 799,590 | Common Stock |
| Klaviyo Inc - Ordinary Shares - Series A | Ms. Amanda Whalen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.75 per share. | 16 Jul 2026 | 14,000 | 838,192 | - | 17.8 | 248,500 | Series A Common Stock |
| Incyte | Dr. Pablo J. Cagnoni, M.D. | President, Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 13,403 | 231,332 (0%) | 0% | 0 | Common Stock | |
| Nerdy Inc (Class A) | Mr. Kyle Callaway | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.83 per share. | 16 Jul 2026 | 13,377 | 487,120 | - | 0.8 | 11,103 | Class A Common Stock |
| Incyte | Mr. Ramitpal K. Basi | EVP, Human Resources | 16 Jul 2026 | 12,479 | 12,479 | - | - | Performance Shares | ||
| Corebridge Fin Inc | Mr. David Ditillo | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 32.00 per share. | 16 Jul 2026 | 12,414 | 119,653 | - | 32 | 397,248 | Common Stock |
| MediaAlpha Inc (Class A) | Mr. Steven M. Yi | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 14.20 per share. | 16 Jul 2026 | 12,333 | 2,459,690 | - | 14.2 | 175,095 | Class A Common Stock |
| JFrog Ltd | Mr. Yossi Sela | Director | Sale of securities on an exchange or to another person at price $ 87.58 per share. | 16 Jul 2026 | 11,923 | 88,425 | - | 87.6 | 1,044,216 | Ordinary Shares |
| Angiodynamic Inc | Mr. James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.51 per share. | 16 Jul 2026 | 11,764 | 841,528 (2%) | 0% | 13.5 | 158,932 | Common Stock |
| Stoke Therapeutics Inc | Dr. Seth L. Harrison, M.D. | Director | 16 Jul 2026 | 11,650 | 11,650 | - | - | Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Dr. Seth L. Harrison, M.D. | Director | 16 Jul 2026 | 11,650 | 0 | - | - | Stock Option (Right to Buy) | ||
| Fastly Inc (Class A) | Mr. Charles Compton | Director, CEO | Sale of securities on an exchange or to another person at price $ 20.65 per share. | 16 Jul 2026 | 11,412 | 1,052,533 (1%) | 0% | 20.7 | 235,658 | Class A Common Stock |
| Intensity Therapeutics Inc | Mr. John Wesolowski | Principal Accounting Officer | 16 Jul 2026 | 11,000 | 11,000 | - | - | Stock Option (right to buy Common Stock) | ||
| International Money Express Inc | Mr. Adam P. Godfrey | Director | Grant, award, or other acquisition of securities at price $ 13.81 per share. | 16 Jul 2026 | 10,862 | 34,064 (0%) | 0% | 13.8 | 150,004 | Common Stock |
| International Money Express Inc | Mr. Michael Purcell | Director | Grant, award, or other acquisition of securities at price $ 13.81 per share. | 16 Jul 2026 | 10,862 | 98,558 (0%) | 0% | 13.8 | 150,004 | Common Stock |
| International Money Express Inc | Ms. Karen A. Higgins-Carter | Director | Grant, award, or other acquisition of securities at price $ 13.81 per share. | 16 Jul 2026 | 10,862 | 36,793 (0%) | 0% | 13.8 | 150,004 | Common Stock |
| International Money Express Inc | Mr. John Rincon | Director | Grant, award, or other acquisition of securities at price $ 13.81 per share. | 16 Jul 2026 | 10,862 | 71,029 (0%) | 0% | 13.8 | 150,004 | Common Stock |
| International Money Express Inc | Ms. Laura I. Maydon | Director | Grant, award, or other acquisition of securities at price $ 13.81 per share. | 16 Jul 2026 | 10,862 | 59,362 (0%) | 0% | 13.8 | 150,004 | Common Stock |
| International Money Express Inc | Dr. Bernardo B. Fernandez, M.D. | Director | Grant, award, or other acquisition of securities at price $ 13.81 per share. | 16 Jul 2026 | 10,862 | 49,335 (0%) | 0% | 13.8 | 150,004 | Common Stock |
| Angiodynamic Inc | Mr. James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.51 per share. | 16 Jul 2026 | 10,649 | 853,292 (2%) | 0% | 13.5 | 143,868 | Common Stock |
| Cintas | Ms. Melanie W. Barstad | Director | 16 Jul 2026 | 10,548 | 0 | - | - | Stock Option (right to buy) | ||
| Cintas | Ms. Melanie W. Barstad | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.10 per share. | 16 Jul 2026 | 10,548 | 37,140 (0%) | 0% | 27.1 | 285,851 | Common Stock |
| Grindr Inc (Class A) | Mr. Zachary Katz | CLO and Head of Global Affairs | Sale of securities on an exchange or to another person at price $ 15.95 per share. | 16 Jul 2026 | 10,172 | 703,151 | - | 15.9 | 162,243 | Common Stock |
| Aehr Test Systems | Mr. Geoffrey G. Scott | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Jul 2026 | 10,000 | 30,686 (0%) | 0% | 0 | Common Stock | |
| First Interstate BancSystem Inc | Mr. Jonathan R. Scott | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 40.30 per share. | 16 Jul 2026 | 10,000 | 842,738 (1%) | 0% | 40.3 | 403,000 | Common Stock |
| MediaAlpha Inc (Class A) | Ms. Amy Yeh | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 14.51 per share. | 16 Jul 2026 | 10,000 | 556,985 | - | 14.5 | 145,080 | Class A Common Stock |
| Abercrombie & Fitch Co. (Class A) | Mr. Scott D. Lipesky | EVP and COO | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 16 Jul 2026 | 10,000 | 182,534 (0%) | 0% | 100 | 1,000,000 | Class A Common Stock |
| Csquare Inc | Mr. Philip M. Kelley | Director | Grant, award, or other acquisition of securities at price $ 21.00 per share. | 16 Jul 2026 | 10,000 | 10,000 | - | 21 | 210,000 | Common Stock |
| Glaukos Corp | Mr. Alex R. Thurman | SVP & CHIEF FINANCIAL OFFICER | 16 Jul 2026 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | ||
| Glaukos Corp | Mr. Alex R. Thurman | SVP & CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 160.00 per share. | 16 Jul 2026 | 10,000 | 43,906 (0%) | 0% | 160 | 1,600,000 | Common Stock |
| Glaukos Corp | Mr. Alex R. Thurman | SVP & CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.68 per share. | 16 Jul 2026 | 10,000 | 53,906 (0%) | 0% | 38.7 | 386,800 | Common Stock |
| Incyte | Dr. Steven H. Stein, M.D. | CMO & Head of Late-Stage Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 9,798 | 30,916 (0%) | 0% | 0 | Common Stock | |
| Monte Rosa Therapeutics Inc | Dr. Markus Warmuth, M.D. | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 23.18 per share. | 16 Jul 2026 | 9,500 | 585,038 | - | 23.2 | 220,219 | Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 16 Jul 2026 | 9,500 | 333,943 (0%) | 0% | 135.4 | 1,286,490 | Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | 16 Jul 2026 | 9,500 | 331,910 | - | - | Stock Option | ||
| Intercontinental Exchange | Ms. Lynn C. Martin | President, NYSE Group | Sale of securities on an exchange or to another person at price $ 141.65 per share. | 16 Jul 2026 | 9,482 | 54,620 (0%) | 0% | 141.6 | 1,343,125 | Common Stock |
| Mobix Labs Inc (Class A) | Mr. Philip Sansone | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.87 per share. | 16 Jul 2026 | 9,301 | 166,130 | - | 1.9 | 17,364 | Class A Common Stock |
| Morgan Stanley | Ms. Sharon Yeshaya | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 222.51 per share. | 16 Jul 2026 | 9,172 | 0 (0%) | 0% | 222.5 | 2,040,862 | Common Stock |
| Cintas | Ms. Melanie W. Barstad | Director | Sale of securities on an exchange or to another person at price $ 202.94 per share. | 16 Jul 2026 | 9,142 | 26,592 (0%) | 0% | 202.9 | 1,855,277 | Common Stock |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 16 Jul 2026 | 8,300 | 53,472 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | 16 Jul 2026 | 8,300 | 80,740 | - | - | Stock Option | ||
| Frontier Nuclear and Minerals | Mr. Jack Wortzman | Director | 16 Jul 2026 | 8,209 | 0 | - | - | Restricted Share Units | ||
| JFrog Ltd | Mr. Yossi Sela | Director | Sale of securities on an exchange or to another person at price $ 86.49 per share. | 16 Jul 2026 | 8,001 | 100,348 | - | 86.5 | 692,006 | Ordinary Shares |
| PubMatic Inc Ordinary Shares | Mr. Mukul Kumar | PRESIDENT, ENGINEERING | 16 Jul 2026 | 8,000 | 135,600 | - | - | Class B Common Stock | ||
| PubMatic Inc Ordinary Shares | Mr. Mukul Kumar | PRESIDENT, ENGINEERING | 16 Jul 2026 | 8,000 | 120,945 | - | 0 | Class A Common Stock | ||
| PubMatic Inc Ordinary Shares | Mr. Mukul Kumar | PRESIDENT, ENGINEERING | Sale of securities on an exchange or to another person at price $ 13.67 per share. | 16 Jul 2026 | 8,000 | 112,945 | - | 13.7 | 109,345 | Class A Common Stock |
| PubMatic Inc Ordinary Shares | Mr. Mukul Kumar | PRESIDENT, ENGINEERING | 16 Jul 2026 | 8,000 | 31,000 | - | - | Stock Option (Right to buy Class B Common Stock) | ||
| PubMatic Inc Ordinary Shares | Mr. Mukul Kumar | PRESIDENT, ENGINEERING | 16 Jul 2026 | 8,000 | 143,600 | - | - | Class B Common Stock | ||
| TripAdvisor Inc | Ms. Kristen Dalton | Chief Strategy & Ops Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 16 Jul 2026 | 7,908 | 117,619 (0%) | 0% | 15 | 118,620 | Common Stock |
| Incyte | Mr. Mohamed Khairie Issa | EVP, Head of U.S. Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 7,857 | 71,797 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Mr. Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.14 per share. | 16 Jul 2026 | 7,840 | 248,789 (0%) | 0% | 14.1 | 110,858 | Common Stock |
| Omnicom Group | Mr. Louis F. Januzzi | Senior VP, Gen. Counsel & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 7,720 | 40,866 (0%) | 0% | 0 | Common Stock, par value $0.15 per share | |
| Exlservice Hldgs Inc | Ms. Kamini H. Mehta | Director | 16 Jul 2026 | 7,705 | 7,705 | - | - | Restricted Stock Units | ||
| Stoke Therapeutics Inc | Dr. Seth L. Harrison, M.D. | Director | 16 Jul 2026 | 7,639 | 7,639 | - | - | Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Dr. Seth L. Harrison, M.D. | Director | 16 Jul 2026 | 7,639 | 0 | - | - | Stock Option (Right to Buy) | ||
| Caredx Inc | Dr. Hannah A. Valantine, M.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.56 per share. | 16 Jul 2026 | 7,606 | 44,292 (0%) | 0% | 20.6 | 156,379 | Common Stock |
| Caredx Inc | Dr. Hannah A. Valantine, M.D. | Director | 16 Jul 2026 | 7,606 | 0 | - | - | Stock Option (Right to Buy) | ||
| Incyte | Mr. David H. Gardner | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 7,395 | 16,824 (0%) | 0% | 0 | Common Stock | |
| Incyte | Mr. Richard A. Hoffman | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 7,395 | 16,861 (0%) | 0% | 0 | Common Stock | |
| Pricesmart Inc | Mr. Robert E. Price | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 189.55 per share. | 16 Jul 2026 | 7,299 | 122,112 (0%) | 0% | 189.5 | 1,383,508 | Common Stock |
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 262.09 per share. | 16 Jul 2026 | 6,869 | 6,359 (0%) | 0% | 262.1 | 1,800,284 | Class A Common Stock |
| Morgan Stanley | Ms. Sharon Yeshaya | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 222.51 per share. | 16 Jul 2026 | 6,382 | 136,809 (0%) | 0% | 222.5 | 1,420,059 | Common Stock |
| Incyte | Mr. Patrick A. Mayes | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 5,916 | 63,628 (0%) | 0% | 0 | Common Stock | |
| Billiontoone Inc Ordinary | Ms. Nancy JoAnn Johnson | See Remarks | Sale of securities on an exchange or to another person at price $ 128.96 per share. | 16 Jul 2026 | 5,601 | 7,806 | - | 129.0 | 722,278 | Class A Common Stock |
| Billiontoone Inc Ordinary | Ms. Nancy JoAnn Johnson | See Remarks | Sale of securities on an exchange or to another person at price $ 127.89 per share. | 16 Jul 2026 | 5,559 | 13,407 | - | 127.9 | 710,918 | Class A Common Stock |
| Intensity Therapeutics Inc | Mr. Thomas I.H. Dubin | Director | 16 Jul 2026 | 5,500 | 5,500 | - | - | Stock Option (right to buy Common Stock) | ||
| Intensity Therapeutics Inc | Dr. Emer Leahy, PhD | Director | 16 Jul 2026 | 5,500 | 5,500 | - | - | Stock Option (right to buy Common Stock) | ||
| People Inc Ordinary Shares | Mr. Alan G. Spoon, J.D. | Director | 16 Jul 2026 | 5,490 | 5,490 | - | - | Restricted Stock Units | ||
| People Inc Ordinary Shares | Mr. David S. Rosenblatt | Director | 16 Jul 2026 | 5,490 | 5,490 | - | - | Restricted Stock Units | ||
| People Inc Ordinary Shares | Mr. Michael D. Eisner | Director | 16 Jul 2026 | 5,490 | 5,490 | - | - | Restricted Stock Units | ||
| People Inc Ordinary Shares | Mr. Richard F. Zannino | Director | 16 Jul 2026 | 5,490 | 5,490 | - | - | Restricted Stock Units | ||
| People Inc Ordinary Shares | Mr. Bryan Lourd | Director | 16 Jul 2026 | 5,490 | 5,490 | - | - | Restricted Stock Units | ||
| People Inc Ordinary Shares | Ms. Bonnie S. Hammer | Director | 16 Jul 2026 | 5,490 | 5,490 | - | - | Restricted Stock Units | ||
| People Inc Ordinary Shares | Mr. Alexander von Furstenberg | Director | 16 Jul 2026 | 5,490 | 5,490 | - | - | Restricted Stock Units | ||
| People Inc Ordinary Shares | Ms. Chelsea Clinton | Director | 16 Jul 2026 | 5,490 | 5,490 | - | - | Restricted Stock Units | ||
| People Inc Ordinary Shares | Mr. Tor R. Braham | Director | 16 Jul 2026 | 5,490 | 5,490 | - | - | Restricted Stock Units | ||
| People Inc Ordinary Shares | Ms. Maria Seferian | Director | 16 Jul 2026 | 5,490 | 5,490 | - | - | Restricted Stock Units | ||
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 261.12 per share. | 16 Jul 2026 | 5,312 | 13,228 (0%) | 0% | 261.1 | 1,387,080 | Class A Common Stock |
| Caredx Inc | Dr. Hannah A. Valantine, M.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.96 per share. | 16 Jul 2026 | 5,125 | 65,465 (0%) | 0% | 8.0 | 40,795 | Common Stock |
| Caredx Inc | Dr. Hannah A. Valantine, M.D. | Director | 16 Jul 2026 | 5,125 | 24,011 | - | - | Stock Option (Right to Buy) | ||
| Adaptive biotech Corp | Ms. Susan Bobulsky | Chief Commercial Officer, MRD | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 16 Jul 2026 | 5,000 | 401,288 (0%) | 0% | 23 | 115,000 | Common Stock |
| AMKOR Tech Inc | Mr. Mark N. Rogers | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 65.12 per share. | 16 Jul 2026 | 5,000 | 38,904 (0%) | 0% | 65.1 | 325,600 | Common Stock |
| AMKOR Tech Inc | Mr. Mark N. Rogers | EVP & General Counsel | 16 Jul 2026 | 5,000 | 75,000 | - | - | Employee Stock Option (Right-to-Buy) | ||
| AMKOR Tech Inc | Mr. Mark N. Rogers | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.40 per share. | 16 Jul 2026 | 5,000 | 43,904 (0%) | 0% | 7.4 | 37,000 | Common Stock |
| BETA Technologies Inc | Mr. Kyle Clark | Director, SEE REMARKS | Sale of securities on an exchange or to another person at price $ 17.52 per share. | 16 Jul 2026 | 5,000 | 5,489,837 | - | 17.5 | 87,592 | Class A common stock |
| Veeva Systems Inc (Class A) | Mr. Thomas D. Schwenger | Pres. & Chief Customer Officer | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 16 Jul 2026 | 5,000 | 20,449 (0%) | 0% | 200 | 1,000,000 | Class A Common Stock |
| Incyte | Mr. Ramitpal K. Basi | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 4,991 | 11,497 (0%) | 0% | 0 | Common Stock | |
| Pricesmart Inc | Mr. Robert E. Price | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 181.75 per share. | 16 Jul 2026 | 4,655 | 109,257 (0%) | 0% | 181.7 | 846,034 | Common Stock |
| JFrog Ltd | Mr. Yossi Sela | Director | Sale of securities on an exchange or to another person at price $ 88.44 per share. | 16 Jul 2026 | 4,576 | 83,849 | - | 88.4 | 404,701 | Ordinary Shares |
| Angiodynamic Inc | Ms. Laura Piccinini | SVP International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.14 per share. | 16 Jul 2026 | 4,538 | 62,218 (0%) | 0% | 14.1 | 64,167 | Common Stock |
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 262.95 per share. | 16 Jul 2026 | 4,419 | 1,940 (0%) | 0% | 263.0 | 1,161,988 | Class A Common Stock |
| Core Scientific Inc - Ordinary Shares - New | Mr. Todd M. Duchene | See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.72 per share. | 16 Jul 2026 | 4,325 | 2,009,101 | - | 22.7 | 98,264 | Common Stock |
| Pricesmart Inc | Mr. Robert E. Price | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 188.81 per share. | 16 Jul 2026 | 4,300 | 117,812 (0%) | 0% | 188.8 | 811,882 | Common Stock |
| Angiodynamic Inc | Mr. James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.71 per share. | 16 Jul 2026 | 4,223 | 836,818 (2%) | 0% | 13.7 | 57,897 | Common Stock |
| Fastly Inc (Class A) | Mr. Charles Compton | Director, CEO | Sale of securities on an exchange or to another person at price $ 21.10 per share. | 16 Jul 2026 | 4,204 | 1,045,615 (1%) | 0% | 21.1 | 88,704 | Class A Common Stock |
| Kinder Morgan (Class P) | Mr. Michael P. Garthwaite | VP (Pres., Products Pipelines) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.30 per share. | 16 Jul 2026 | 4,145 | 51,963 (0%) | 0% | 32.3 | 133,884 | Class P Common Stock |
| Incyte | Mr. Thomas Tray | Principal Accounting Officer | 16 Jul 2026 | 4,079 | 4,079 | - | - | Employee Stock Option (right to buy) | ||
| Uber | Mr. Andrew G. Macdonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 4,042 | 357,520 (0%) | 0% | - | Common Stock | |
| Uber | Mr. Andrew G. Macdonald | See Remarks | 16 Jul 2026 | 4,042 | 32,337 | - | - | Restricted Stock Units | ||
| Corebridge Fin Inc | Mr. David Ditillo | Chief Information Officer | 16 Jul 2026 | 3,914 | 22,828 | - | - | Options (Rights to Buy) | ||
| Corebridge Fin Inc | Mr. David Ditillo | Chief Information Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.30 per share. | 16 Jul 2026 | 3,914 | 132,067 | - | 20.3 | 79,454 | Common Stock |
| Pricesmart Inc | Mr. Robert E. Price | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 186.96 per share. | 16 Jul 2026 | 3,700 | 114,112 (0%) | 0% | 187.0 | 691,747 | Common Stock |
| Csquare Inc | Ms. Terri A. Pizzuto | Director | Grant, award, or other acquisition of securities at price $ 21.00 per share. | 16 Jul 2026 | 3,600 | 3,600 | - | 21 | 75,600 | Common Stock |
| Angiodynamic Inc | Mr. Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.51 per share. | 16 Jul 2026 | 3,510 | 245,279 (0%) | 0% | 13.5 | 47,420 | Common Stock |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 534.21 per share. | 16 Jul 2026 | 3,279 | 47,812 (0%) | 0% | 534.2 | 1,751,679 | Common Stock |
| Honeywell Aerospace Inc | Mr. James Currier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 3,253 | 5,514 | - | - | Common Stock | |
| Honeywell Aerospace Inc | Mr. James Currier | Director, President and CEO | 16 Jul 2026 | 3,253 | 3,047 | - | - | Restricted Stock Units | ||
| PubMatic Inc Ordinary Shares | Mr. Andrew Woods | GENERAL COUNSEL & SECRETARY | Sale of securities on an exchange or to another person at price $ 14.01 per share. | 16 Jul 2026 | 3,239 | 78,092 | - | 14.0 | 45,375 | Class A Common Stock |
| Intercontinental Exchange | Ms. Lynn C. Martin | President, NYSE Group | Sale of securities on an exchange or to another person at price $ 140.90 per share. | 16 Jul 2026 | 3,200 | 64,102 (0%) | 0% | 140.9 | 450,892 | Common Stock |
| Domino's Pizza | Mr. Joseph Hugh Jordan | COO and President-Dominos US | 16 Jul 2026 | 3,100 | 0 | - | - | Option to Purchase Common Stock | ||
| Domino's Pizza | Mr. Joseph Hugh Jordan | COO and President-Dominos US | Sale of securities on an exchange or to another person at price $ 311.29 per share. | 16 Jul 2026 | 3,100 | 10,905 (0%) | 0% | 311.3 | 964,999 | Common Stock, $0.01 par value |
| Domino's Pizza | Mr. Joseph Hugh Jordan | COO and President-Dominos US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 136.89 per share. | 16 Jul 2026 | 3,100 | 14,005 (0%) | 0% | 136.9 | 424,359 | Common Stock, $0.01 par value |
| Honeywell | Mr. Vimal Kapur | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 3,090 | 3,380 (0%) | 0% | - | Common Stock | |
| Honeywell | Mr. Vimal Kapur | Director, Chief Executive Officer | 16 Jul 2026 | 3,090 | 0 | - | - | Restricted Stock Units | ||
| Angiodynamic Inc | Ms. Laura Piccinini | SVP International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.51 per share. | 16 Jul 2026 | 3,074 | 59,144 (0%) | 0% | 13.5 | 41,530 | Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 529.46 per share. | 16 Jul 2026 | 3,057 | 329,406 (0%) | 0% | 529.5 | 1,618,572 | Common Stock |
| Farmers & Merchants Bancorp Inc | Mr. Andrew J. Briggs | Director | Sale of securities on an exchange or to another person at price $ 30.06 per share. | 16 Jul 2026 | 3,000 | 117,550 (1%) | 0% | 30.1 | 90,180 | Common Stock |
| Farmers & Merchants Bancorp Inc | Mr. Andrew J. Briggs | Director | Sale of securities on an exchange or to another person at price $ 31.06 per share. | 16 Jul 2026 | 3,000 | 114,550 (1%) | 0% | 31.1 | 93,180 | Common Stock |
| MediaAlpha Inc (Class A) | Ms. Amy Yeh | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 13.95 per share. | 16 Jul 2026 | 3,000 | 553,985 | - | 14.0 | 41,850 | Class A Common Stock |
| Intercontinental Exchange | Ms. Lynn C. Martin | President, NYSE Group | Sale of securities on an exchange or to another person at price $ 139.75 per share. | 16 Jul 2026 | 3,000 | 67,302 (0%) | 0% | 139.7 | 419,237 | Common Stock |
| Uber | Mr. Tony West | See Remarks | 16 Jul 2026 | 2,910 | 23,283 | - | - | Restricted Stock Units | ||
| Uber | Mr. Tony West | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 2,910 | 254,816 (0%) | 0% | - | Common Stock | |
| Incyte | Mr. Thomas Tray | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 2,834 | 21,699 (0%) | 0% | 0 | Common Stock | |
| Burke & Herbert Fin Services Corp | Mr. Bradford E. Ritchie | EVP, Chief Lending Officer | 16 Jul 2026 | 2,749 | 0 | - | - | Stock Settled Appreciation Rights | ||
| Burke & Herbert Fin Services Corp | Mr. Bradford E. Ritchie | EVP, Chief Lending Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.58 per share. | 16 Jul 2026 | 2,749 | 25,827 | - | 51.6 | 141,793 | Common Stock |
| Fastly Inc (Class A) | Mr. Charles Compton | Director, CEO | Sale of securities on an exchange or to another person at price $ 20.51 per share. | 16 Jul 2026 | 2,714 | 1,049,819 (1%) | 0% | 20.5 | 55,664 | Class A Common Stock |
| Ennis Inc | Mr. Alejandro Quiroz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 2,661 | 17,020 (0%) | 0% | 0 | Common Stock | |
| Ennis Inc | Mr. Troy L. Priddy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 2,661 | 25,825 (0%) | 0% | 0 | Common Stock | |
| Ennis Inc | Mr. Gary S. Mozina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 2,661 | 23,531 (0%) | 0% | 0 | Common Stock | |
| Ennis Inc | Ms. Barbara T. Clemens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 2,661 | 26,531 (0%) | 0% | 0 | Common Stock | |
| Ennis Inc | Mr. Aaron Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 2,661 | 21,046 (0%) | 0% | 0 | Common Stock | |
| Ennis Inc | Ms. Margaret A. Walters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 2,661 | 18,141 (0%) | 0% | 0 | Common Stock | |
| Ennis Inc | Mr. Walter D. Gruenes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 2,661 | 13,404 (0%) | 0% | 0 | Common Stock | |
| Honeywell | Mr. Michal Stepniak | SrVP & Chief Financial Officer | 16 Jul 2026 | 2,575 | 0 | - | - | Restricted Stock Units | ||
| Honeywell | Mr. Michal Stepniak | SrVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 2,575 | 3,488 (0%) | 0% | - | Common Stock | |
| Uber | Ms. Jill Hazelbaker | See Remarks | 16 Jul 2026 | 2,547 | 20,372 | - | - | Restricted Stock Units | ||
| Uber | Ms. Jill Hazelbaker | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 2,547 | 177,790 (0%) | 0% | - | Common Stock | |
| Uber | Mr. Andrew G. Macdonald | See Remarks | 16 Jul 2026 | 2,520 | 50,396 | - | - | Restricted Stock Units | ||
| Uber | Mr. Andrew G. Macdonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 2,520 | 353,478 (0%) | 0% | - | Common Stock | |
| Chiron Real Estate Inc | Mr. Robert Harold Zeiller | See Remarks | 16 Jul 2026 | 2,477 | 2,477 | - | - | LTIP Unit (Right to Buy) | ||
| Uber | Mr. Andrew G. Macdonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 2,473 | 350,958 (0%) | 0% | - | Common Stock | |
| Uber | Mr. Andrew G. Macdonald | See Remarks | 16 Jul 2026 | 2,473 | 79,113 | - | - | Restricted Stock Units | ||
| Angiodynamic Inc | Mr. Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.14 per share. | 16 Jul 2026 | 2,367 | 89,930 (0%) | 0% | 14.1 | 33,469 | Common Stock |
| Domino's Pizza | Mr. Joseph Hugh Jordan | COO and President-Dominos US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 136.89 per share. | 16 Jul 2026 | 2,350 | 13,255 (0%) | 0% | 136.9 | 321,692 | Common Stock, $0.01 par value |
| Domino's Pizza | Mr. Joseph Hugh Jordan | COO and President-Dominos US | 16 Jul 2026 | 2,350 | 0 | - | - | Option to Purchase Common Stock | ||
| Domino's Pizza | Mr. Joseph Hugh Jordan | COO and President-Dominos US | Sale of securities on an exchange or to another person at price $ 311.29 per share. | 16 Jul 2026 | 2,350 | 10,905 (0%) | 0% | 311.3 | 731,532 | Common Stock, $0.01 par value |
| Angiodynamic Inc | Mr. Lawrence T Weiss | SVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.14 per share. | 16 Jul 2026 | 2,267 | 91,330 (0%) | 0% | 14.1 | 32,055 | Common Stock |
| Uber | Mr. Andrew G. Macdonald | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.04 per share. | 16 Jul 2026 | 2,259 | 351,837 (0%) | 0% | 74.0 | 167,256 | Common Stock |
| Advanced Drainage Systems Inc | Mr. Robert M. Eversole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 2,253 | 4,639 (0%) | 0% | 0 | Common Stock | |
| Burke & Herbert Fin Services Corp | Mr. Bradford E. Ritchie | EVP, Chief Lending Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.76 per share. | 16 Jul 2026 | 2,222 | 23,605 | - | 70.8 | 157,229 | Common Stock |
| BlackRock | Mr. Christopher J. Meade | General Counsel and CLO | Sale of securities on an exchange or to another person at price $ 1102.80 per share. | 16 Jul 2026 | 2,200 | 14,059 (0%) | 0% | 1102.8 | 2,426,152 | Common Stock |
| Angiodynamic Inc | Mr. Warren G. Nighan, Jr | SVP Quality and Regulatory | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.14 per share. | 16 Jul 2026 | 2,153 | 67,750 (0%) | 0% | 14.1 | 30,443 | Common Stock |
| Astrotech Corp | Mr. Eric Stober | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 2,150 | 18,487 (0%) | 0% | 0 | Common Stock | |
| Astrotech Corp | Mr. John Halinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 2,150 | 11,156 (0%) | 0% | 0 | Common Stock | |
| Astrotech Corp | Mr. Matthew Kreps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 2,150 | 2,150 (0%) | 0% | 0 | Common Stock | |
| Astrotech Corp | Mr. Eric Stober | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 2,150 | 19,654 (0%) | 0% | 0 | Common Stock | |
| Astrotech Corp | Mr. John Halinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 2,150 | 12,211 (0%) | 0% | 0 | Common Stock | |
| Billiontoone Inc Ordinary | Ms. Nancy JoAnn Johnson | See Remarks | Sale of securities on an exchange or to another person at price $ 126.98 per share. | 16 Jul 2026 | 2,133 | 18,966 | - | 127.0 | 270,853 | Class A Common Stock |
| Korn Ferry | Ms. Lesley Uren | CEO of Consulting | Sale of securities on an exchange or to another person at price $ 78.75 per share. | 16 Jul 2026 | 2,000 | 30,109 (0%) | 0% | 78.8 | 157,500 | Common Stock, par value $0.01 per share |
| Townsquare Media Inc (Class A) | Mr. Scott Schatz | EVP, Finance Op and Tech | Grant, award, or other acquisition of securities at price $ 4.57 per share. | 16 Jul 2026 | 2,000 | 70,994 (0%) | 0% | 4.6 | 9,140 | Class A Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 530.15 per share. | 16 Jul 2026 | 1,924 | 327,482 (0%) | 0% | 530.1 | 1,019,999 | Common Stock |
| BlackRock | Mr. Laurence D. Fink | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 1080.57 per share. | 16 Jul 2026 | 1,905 | 223,831 (0%) | 0% | 1080.6 | 2,058,486 | Shares Of Common Stock (par Value $0.01 Per Share) |
| Uber | Ms. Jill Hazelbaker | See Remarks | 16 Jul 2026 | 1,888 | 83,076 | - | - | Restricted Stock Units | ||
| Uber | Ms. Jill Hazelbaker | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,888 | 172,285 (0%) | 0% | - | Common Stock | |
| Honeywell | Mr. James Masso | Pres/CEO, Process Automation | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,879 | 1,879 (0%) | 0% | - | Common Stock | |
| Honeywell | Mr. James Masso | Pres/CEO, Process Automation | 16 Jul 2026 | 1,879 | 3,733 | - | - | Restricted Stock Units | ||
| Incyte | Dr. Steven H. Stein, M.D. | CMO & Head of Late-Stage Dev. | Sale of securities on an exchange or to another person at price $ 114.73 per share. | 16 Jul 2026 | 1,877 | 21,118 (0%) | 0% | 114.7 | 215,348 | Common Stock |
| Advanced Drainage Systems Inc | Mr. Anil Seetharam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 1,782 | 16,240 (0%) | 0% | 0 | Common Stock | |
| Ooma Inc | Ms. Jenny C. Yeh | Director, SVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 21.00 per share. | 16 Jul 2026 | 1,762 | 260,372 (1%) | 0% | 21 | 37,002 | Common Stock |
| Honeywell Aerospace Inc | Ms. Karen Elizabeth Arlak | SVP and CHRO | 16 Jul 2026 | 1,756 | 1,663 | - | - | Restricted Stock Units | ||
| Honeywell Aerospace Inc | Ms. Karen Elizabeth Arlak | SVP and CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,756 | 4,363 | - | - | Common Stock | |
| ImageneBio Inc | Mr. Robert B. Lally | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 5.50 per share. | 16 Jul 2026 | 1,671 | 57,107 | - | 5.5 | 9,191 | Common Stock |
| ABM Ind Inc | Mr. Raul Javier Valentin | EVP and CHRO | Sale of securities on an exchange or to another person at price $ 48.00 per share. | 16 Jul 2026 | 1,639 | 49,036 (0%) | 0% | 48 | 78,672 | Common Stock |
| Walmart | Mr. Christopher Nicholas | Executive Vice President | Sale of securities on an exchange or to another person at price $ 113.87 per share. | 16 Jul 2026 | 1,639 | 573,314 (0%) | 0% | 113.9 | 186,640 | Common |
| Townsquare Media Inc (Class A) | Mr. Robert L. Worshek | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 4.57 per share. | 16 Jul 2026 | 1,558 | 144,280 (1%) | 0% | 4.6 | 7,120 | Class A Common Stock |
| Kinder Morgan (Class P) | Mr. Michael P. Garthwaite | VP (Pres., Products Pipelines) | Sale of securities on an exchange or to another person at price $ 32.52 per share. | 16 Jul 2026 | 1,550 | 40,193 (0%) | 0% | 32.5 | 50,400 | Class P Common Stock |
| ImageneBio Inc | Mr. Robert B. Lally | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 5.34 per share. | 16 Jul 2026 | 1,525 | 55,582 | - | 5.3 | 8,144 | Common Stock |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 534.99 per share. | 16 Jul 2026 | 1,519 | 45,252 (0%) | 0% | 535.0 | 812,648 | Common Stock |
| Uber | Mr. Glen Ceremony | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,516 | 264,787 (0%) | 0% | - | Common Stock | |
| Uber | Mr. Glen Ceremony | See Remarks | 16 Jul 2026 | 1,516 | 12,126 | - | - | Restricted Stock Units | ||
| Uber | Mr. Tony West | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,511 | 249,131 (0%) | 0% | - | Common Stock | |
| Uber | Mr. Tony West | See Remarks | 16 Jul 2026 | 1,511 | 66,461 | - | - | Restricted Stock Units | ||
| Uber | Mr. Tony West | See Remarks | 16 Jul 2026 | 1,493 | 29,864 | - | - | Restricted Stock Units | ||
| Uber | Mr. Tony West | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,493 | 251,906 (0%) | 0% | - | Common Stock | |
| Uber | Ms. Jill Hazelbaker | See Remarks | 16 Jul 2026 | 1,493 | 29,864 | - | - | Restricted Stock Units | ||
| Uber | Ms. Jill Hazelbaker | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,493 | 175,243 (0%) | 0% | - | Common Stock | |
| Uber | Ms. Jill Hazelbaker | See Remarks | 16 Jul 2026 | 1,465 | 46,882 | - | - | Restricted Stock Units | ||
| Uber | Ms. Jill Hazelbaker | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,465 | 173,750 (0%) | 0% | - | Common Stock | |
| Uber | Mr. Tony West | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.04 per share. | 16 Jul 2026 | 1,443 | 251,246 (0%) | 0% | 74.0 | 106,840 | Common Stock |
| Uber | Ms. Jill Hazelbaker | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,416 | 170,397 (0%) | 0% | - | Common Stock | |
| Uber | Ms. Jill Hazelbaker | See Remarks | 16 Jul 2026 | 1,416 | 62,307 | - | - | Restricted Stock Units | ||
| Uber | Mr. Andrew G. Macdonald | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.04 per share. | 16 Jul 2026 | 1,409 | 354,096 (0%) | 0% | 74.0 | 104,322 | Common Stock |
| Cintas | Ms. Melanie W. Barstad | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 203.44 per share. | 16 Jul 2026 | 1,406 | 35,734 (0%) | 0% | 203.4 | 286,037 | Common Stock |
| Performance Food Grp Co | Mr. George L. Holm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 111.94 per share. | 16 Jul 2026 | 1,403 | 1,653,149 (1%) | 0% | 111.9 | 157,052 | Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 528.42 per share. | 16 Jul 2026 | 1,400 | 332,463 (0%) | 0% | 528.4 | 739,783 | Common Stock |
| Uber | Mr. Andrew G. Macdonald | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.04 per share. | 16 Jul 2026 | 1,382 | 355,505 (0%) | 0% | 74.0 | 102,323 | Common Stock |
| Angiodynamic Inc | Mr. Warren G. Nighan, Jr | SVP Quality and Regulatory | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.51 per share. | 16 Jul 2026 | 1,373 | 66,377 (0%) | 0% | 13.5 | 18,549 | Common Stock |
| Honeywell Aerospace Inc | Mr. James Currier | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 208.37 per share. | 16 Jul 2026 | 1,362 | 4,152 | - | 208.4 | 283,800 | Common Stock |
| Honeywell | Mr. Vimal Kapur | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.58 per share. | 16 Jul 2026 | 1,343 | 2,037 (0%) | 0% | 239.6 | 321,756 | Common Stock |
| Uber | Ms. Jill Hazelbaker | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.04 per share. | 16 Jul 2026 | 1,314 | 173,162 (0%) | 0% | 74.0 | 97,289 | Common Stock |
| Uber | Mr. Tony West | See Remarks | 16 Jul 2026 | 1,282 | 41,022 | - | - | Restricted Stock Units | ||
| Uber | Mr. Tony West | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,282 | 250,413 (0%) | 0% | - | Common Stock | |
| Walmart | Mr. Christopher Nicholas | Executive Vice President | Sale of securities on an exchange or to another person at price $ 114.48 per share. | 16 Jul 2026 | 1,261 | 572,053 (0%) | 0% | 114.5 | 144,358 | Common |
| Academy Sports and Outdoors Inc | Mr. Jeffrey C. Tweedy | Director | Sale of securities on an exchange or to another person at price $ 48.00 per share. | 16 Jul 2026 | 1,200 | 10,567 | - | 48 | 57,600 | Common Stock |
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 259.79 per share. | 16 Jul 2026 | 1,200 | 18,540 (0%) | 0% | 259.8 | 311,744 | Class A Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 534.31 per share. | 16 Jul 2026 | 1,198 | 325,324 (0%) | 0% | 534.3 | 640,101 | Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Mr. Steven P. Coen | See remarks | 16 Jul 2026 | 1,174 | 5,883 | - | - | Restricted Stock Units | ||
| Ginkgo Bioworks Holdings Inc (Class A) | Mr. Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,174 | 51,878 | - | - | Class A Common Stock | |
| Uber | Mr. Balaji Krishnamurthy | Chief Financial Officer | 16 Jul 2026 | 1,158 | 16,211 | - | - | Restricted Stock Units | ||
| Uber | Mr. Balaji Krishnamurthy | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,158 | 40,902 (0%) | 0% | - | Common Stock | |
| Uber | Mr. Andrew G. Macdonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,132 | 348,485 (0%) | 0% | - | Common Stock | |
| Uber | Mr. Andrew G. Macdonald | See Remarks | 16 Jul 2026 | 1,132 | 49,846 | - | - | Restricted Stock Units | ||
| Akari Therapeutics PLC (ADR) | Mr. Kameel D. Farag | Interim CFO | Grant, award, or other acquisition of securities at price $ 11.50 per share. | 16 Jul 2026 | 1,130 | 21,581 (0%) | 0% | 11.5 | 12,995 | American Depositary Shares representing Ordinary Shares |
| Honeywell | Mr. Michal Stepniak | SrVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.58 per share. | 16 Jul 2026 | 1,124 | 2,364 (0%) | 0% | 239.6 | 269,288 | Common Stock |
| Angiodynamic Inc | Mr. Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.51 per share. | 16 Jul 2026 | 1,112 | 88,818 (0%) | 0% | 13.5 | 15,023 | Common Stock |
| Advanced Drainage Systems Inc | Ms. Tanya D Fratto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 1,110 | 30,552 (0%) | 0% | 0 | Common Stock | |
| Advanced Drainage Systems Inc | Ms. Anesa T. Chaibi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 1,110 | 8,698 (0%) | 0% | 0 | Common Stock | |
| Advanced Drainage Systems Inc | Mr. Alexander R. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 1,110 | 17,564 (0%) | 0% | 0 | Common Stock | |
| Advanced Drainage Systems Inc | Mr. Michael B. Coleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 1,110 | 12,587 (0%) | 0% | 0 | Common Stock | |
| Advanced Drainage Systems Inc | Ms. Kelly S. Gast | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 1,110 | 8,981 (0%) | 0% | 0 | Common Stock | |
| Pricesmart Inc | Mr. Robert E. Price | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 191.15 per share. | 16 Jul 2026 | 1,100 | 129,411 (0%) | 0% | 191.2 | 210,266 | Common Stock |
| Incyte | Mr. Mohamed Khairie Issa | EVP, Head of U.S. Commercial | Sale of securities on an exchange or to another person at price $ 115.01 per share. | 16 Jul 2026 | 1,093 | 63,940 (0%) | 0% | 115.0 | 125,706 | Common Stock |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 535.88 per share. | 16 Jul 2026 | 1,041 | 46,771 (0%) | 0% | 535.9 | 557,851 | Common Stock |
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 258.89 per share. | 16 Jul 2026 | 1,040 | 19,740 (0%) | 0% | 258.9 | 269,245 | Class A Common Stock |
| Honeywell | Mr. Billal M. Hammoud | Pres/CEO Building Automation | 16 Jul 2026 | 1,030 | 0 | - | - | Restricted Stock Units | ||
| Honeywell | Mr. Billal M. Hammoud | Pres/CEO Building Automation | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,030 | 3,848 (0%) | 0% | - | Common Stock | |
| Honeywell | Mr. Kenneth J. West | Pres/CEO Process Technologies | 16 Jul 2026 | 1,030 | 0 | - | - | Restricted Stock Units | ||
| Honeywell | Mr. Kenneth J. West | Pres/CEO Process Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,030 | 2,681 (0%) | 0% | - | Common Stock | |
| Torrid Holdings Inc | Ms. Chinwe Abaelu | See Remarks | Sale of securities on an exchange or to another person at price $ 2.29 per share. | 16 Jul 2026 | 1,000 | 201,461 | - | 2.3 | 2,290 | Common Stock |
| CRA Intl Inc | Ms. Christine R. Detrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 989 | 7,128 (0%) | 0% | 0 | Common Stock | |
| CRA Intl Inc | Mr. Richard D. Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 989 | 9,924 (0%) | 0% | 0 | Common Stock | |
| CRA Intl Inc | Mr. Thomas A. Avery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 989 | 15,328 (0%) | 0% | 0 | Common Stock | |
| CRA Intl Inc | Ms. Karen C. Keenan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 989 | 3,389 (0%) | 0% | 0 | Common Stock | |
| CRA Intl Inc | Ms. Heather E. Tookes, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 989 | 3,806 (0%) | 0% | 0 | Common Stock | |
| CRA Intl Inc | Dr. Alva Harry Taylor, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 989 | 4,372 (0%) | 0% | 0 | Common Stock | |
| Uber | Ms. Jill Hazelbaker | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.04 per share. | 16 Jul 2026 | 946 | 175,958 (0%) | 0% | 74.0 | 70,042 | Common Stock |
| Billiontoone Inc Ordinary | Ms. Nancy JoAnn Johnson | See Remarks | Sale of securities on an exchange or to another person at price $ 129.78 per share. | 16 Jul 2026 | 906 | 6,900 | - | 129.8 | 117,580 | Class A Common Stock |
| Jasper Therapeutics Inc | Mr. Patrick J. Crutcher | Director | 16 Jul 2026 | 888 | 888 | - | - | Non-Voting Convertible Preferred Stock | ||
| Ennis Inc | Mr. Michael D. Magill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 887 | 13,720 (0%) | 0% | 0 | Common Stock | |
| Uber | Mr. Balaji Krishnamurthy | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 885 | 38,568 (0%) | 0% | - | Common Stock | |
| Uber | Mr. Balaji Krishnamurthy | Chief Financial Officer | 16 Jul 2026 | 885 | 38,492 | - | - | Restricted Stock Units | ||
| Alpha & Omega Semiconductor Ltd | Dr. Bing Xue, PhD | EVP-WW Sales & Bus Development | Sale of securities on an exchange or to another person at price $ 33.99 per share. | 16 Jul 2026 | 875 | 122,785 (0%) | 0% | 34.0 | 29,741 | Common Share |
| Schrodinger Inc | Mr. Rachit Jain | EVP & CFO | Sale of securities on an exchange or to another person at price $ 15.60 per share. | 16 Jul 2026 | 875 | 50,877 (0%) | 0% | 15.6 | 13,647 | Common Stock |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 531.97 per share. | 16 Jul 2026 | 861 | 51,891 (0%) | 0% | 532.0 | 458,025 | Common Stock |
| Rockwell | Mr. Terry L. Riesterer | Vice President and Controller | 16 Jul 2026 | 849 | 850 | - | - | Restricted Stock Units | ||
| Rockwell | Mr. Terry L. Riesterer | Vice President and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 849 | 1,883 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 532.94 per share. | 16 Jul 2026 | 800 | 51,091 (0%) | 0% | 532.9 | 426,352 | Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Mr. Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 7.90 per share. | 16 Jul 2026 | 752 | 51,438 | - | 7.9 | 5,943 | Class A Common Stock |
| Uber | Mr. Glen Ceremony | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.04 per share. | 16 Jul 2026 | 752 | 262,994 (0%) | 0% | 74.0 | 55,678 | Common Stock |
| Uber | Mr. Tony West | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.04 per share. | 16 Jul 2026 | 750 | 254,066 (0%) | 0% | 74.0 | 55,530 | Common Stock |
| Uber | Ms. Jill Hazelbaker | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.04 per share. | 16 Jul 2026 | 748 | 174,476 (0%) | 0% | 74.0 | 55,382 | Common Stock |
| Uber | Mr. Tony West | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.04 per share. | 16 Jul 2026 | 741 | 252,689 (0%) | 0% | 74.0 | 54,864 | Common Stock |
| Uber | Ms. Jill Hazelbaker | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.04 per share. | 16 Jul 2026 | 734 | 175,224 (0%) | 0% | 74.0 | 54,345 | Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 535.20 per share. | 16 Jul 2026 | 720 | 324,604 (0%) | 0% | 535.2 | 385,342 | Common Stock |
| Angiodynamic Inc | Mr. Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.71 per share. | 16 Jul 2026 | 717 | 244,562 (0%) | 0% | 13.7 | 9,830 | Common Stock |
| Uber | Ms. Jill Hazelbaker | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.04 per share. | 16 Jul 2026 | 710 | 176,904 (0%) | 0% | 74.0 | 52,568 | Common Stock |
| Uber | Mr. Glen Ceremony | See Remarks | 16 Jul 2026 | 708 | 31,153 | - | - | Restricted Stock Units | ||
| Uber | Mr. Glen Ceremony | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 708 | 261,884 (0%) | 0% | - | Common Stock | |
| Uber | Mr. Glen Ceremony | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 700 | 263,271 (0%) | 0% | - | Common Stock | |
| Uber | Mr. Glen Ceremony | See Remarks | 16 Jul 2026 | 700 | 13,999 | - | - | Restricted Stock Units | ||
| Uber | Mr. Glen Ceremony | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 687 | 262,571 (0%) | 0% | - | Common Stock | |
| Uber | Mr. Glen Ceremony | See Remarks | 16 Jul 2026 | 687 | 21,976 | - | - | Restricted Stock Units |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.